Mirae Asset Global Investments »

Denali Therapeutics shares owned by Mirae Asset Global Investments

Quarter-by-quarter ownership of Denali Therapeutics (DNLI) shares owned by Mirae Asset Global Investments from 13F filings

Historical chart of Mirae Asset Global Investments investment in Denali Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Denali Therapeutics held by Mirae Asset Global Investments consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Denali Therapeutics by Mirae Asset Global Investments

Quarter filed Position value Share count Share price at filing
2025-09-30 $82k 5.7k 14.52
2025-06-30 $79k 5.6k 13.99
2025-03-31 $72k 4.9k 14.78
2024-12-31 $99k 4.8k 20.61
2024-09-30 $152k 5.2k 29.43
2024-06-30 $98k 4.3k 22.97
2024-03-31 $1.5M 71k 20.52
2023-12-31 $1.6M 74k 21.46
2023-09-30 $1.4M 70k 20.63
2023-06-30 $2.1M 70k 29.51
2023-03-31 $1.5M 67k 23.04
2022-12-31 $1.5M 55k 27.81
2022-09-30 $1.5M 49k 30.54
2022-06-30 $1.0M 35k 29.44
2021-09-30 $460k 5.9k 78.49
2021-06-30 $460k 5.9k 78.49